“…Platelet-rich fibrin (PRF) is a second-generation platelet concentrate to replace platelet-rich plasma (PRP), and has become an attractive strategy in tissue grafting and regenerative medicine because it has abundant tissue healing-promoting cytokines and interleukins (ILs), including transforming growth factor beta 1 (TGF-β1), basic fibroblast growth factor (bFGF), platelet derived growth factor (PDGF), vascular endothelial growth factor (VEGF), IL-6, IL-8, IL-11, and so on (Masuki et al, 2016). Furthermore, PRF has been verified to increase tissue retention, quality, and neovascularized capillary density of grafted fat (Xiong et al, 2019). In addition, PRF has also been demonstrated to facilitate the regeneration of bone, periodontal tissue, and dental pulp (Chang and Zhao, 2011;Ji et al, 2015;You et al, 2019).…”